BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24396872)

  • 1. Vaccinomics, the new road to tick vaccines.
    de la Fuente J; Merino O
    Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for new and improved vaccines against ticks and tick-borne diseases.
    de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
    Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinomics Approach to Tick Vaccine Development.
    Contreras M; Villar M; Alberdi P; de la Fuente J
    Methods Mol Biol; 2016; 1404():275-286. PubMed ID: 27076305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tick vaccines and the transmission of tick-borne pathogens.
    de la Fuente J; Kocan KM; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches towards tick and tick-borne diseases control.
    Domingos A; Antunes S; Borges L; Rosário VE
    Rev Soc Bras Med Trop; 2013; 46(3):265-9. PubMed ID: 23559344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying proteomics to tick vaccine development: where are we?
    Villar M; Marina A; de la Fuente J
    Expert Rev Proteomics; 2017 Mar; 14(3):211-221. PubMed ID: 28099817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput discovery and characterization of tick and pathogen vaccine protective antigens using vaccinomics with intelligent Big Data analytic techniques.
    De La Fuente J; Villar M; Estrada-Peña A; Olivas JA
    Expert Rev Vaccines; 2018 Jul; 17(7):569-576. PubMed ID: 29953298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and control strategies for ticks and pathogen transmission.
    de La Fuente J; Kocan KM; Contreras M
    Rev Sci Tech; 2015 Apr; 34(1):249-64. PubMed ID: 26470461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tick and pathogen transmission blocking vaccines.
    van Oosterwijk JG
    Parasite Immunol; 2021 May; 43(5):e12831. PubMed ID: 33704804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
    Nuttall PA; Trimnell AR; Kazimirova M; Labuda M
    Parasite Immunol; 2006 Apr; 28(4):155-63. PubMed ID: 16542317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative approaches for the control of ticks and tick-borne diseases.
    de la Fuente J; Mazuecos L; Contreras M
    Ticks Tick Borne Dis; 2023 Nov; 14(6):102227. PubMed ID: 37419001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine approaches applied to controlling dog ticks.
    Ribeiro HS; Pereira DFS; Melo-Junior O; Mariano RMDS; Leite JC; Silva AVD; Oliveira DS; Gonçalves AAM; Lair DF; Soares IDS; Santos TAP; Galdino AS; Silveira-Lemos DD; Paes PRO; Melo MM; Dutra WO; Araujo RN; Giunchetti RC
    Ticks Tick Borne Dis; 2021 May; 12(3):101631. PubMed ID: 33494026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
    Artigas-Jerónimo S; De La Fuente J; Villar M
    Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ten-year review of commercial vaccine performance for control of tick infestations on cattle.
    de la Fuente J; Almazán C; Canales M; Pérez de la Lastra JM; Kocan KM; Willadsen P
    Anim Health Res Rev; 2007 Jun; 8(1):23-8. PubMed ID: 17692140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and
    Contreras M; Alberdi P; Fernández De Mera IG; Krull C; Nijhof A; Villar M; De La Fuente J
    Front Cell Infect Microbiol; 2017; 7():360. PubMed ID: 28848718
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospects for vaccination against the ticks of pets and the potential impact on pathogen transmission.
    de la Fuente J; Villar M; Contreras M; Moreno-Cid JA; Merino O; Pérez de la Lastra JM; de la Fuente G; Galindo RC
    Vet Parasitol; 2015 Feb; 208(1-2):26-9. PubMed ID: 25555312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.